A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma (Q36437111)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma |
scientific article |
Statements
1 reference
A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma (English)
1 reference
Tanios Bekaii-Saab
1 reference
Eric A Collisson
1 reference
Andrew H Ko
1 reference
Jessica Van Ziffle
1 reference
Olga M Mirzoeva
1 reference
Nancy M Joseph
1 reference
AmirAli Talasaz
1 reference
Peter Kuhn
1 reference
Margaret A Tempero
1 reference
R Kate Kelley
1 reference
Alan P Venook
1 reference
Elizabeth Dito
1 reference
Anna Ong
1 reference
Sharvina Ziyeh
1 reference
Ryan Courtin
1 reference
Regina Linetskaya
1 reference
Sanaa Tahiri
1 reference
W Michael Korn
1 reference
6 August 2015
1 reference
1 reference
61-68
1 reference
Identifiers
1 reference
1 reference
1 reference